David Moore, MD, PhD
DownloadHi-Res Photo
Cards
Appointments
Psychiatry
Primary
Titles
Director, VISN 1 Clinical Resource Hub; Chief, Clinical Resource Hub Service Line; Director, National Expert Consultation and Specialty Services - Mental Health
Contact Info
Appointments
Psychiatry
Primary
Titles
Director, VISN 1 Clinical Resource Hub; Chief, Clinical Resource Hub Service Line; Director, National Expert Consultation and Specialty Services - Mental Health
Contact Info
Appointments
Psychiatry
Primary
Titles
Director, VISN 1 Clinical Resource Hub; Chief, Clinical Resource Hub Service Line; Director, National Expert Consultation and Specialty Services - Mental Health
Contact Info
About
Titles
Associate Professor of Psychiatry
Director, VISN 1 Clinical Resource Hub; Chief, Clinical Resource Hub Service Line; Director, National Expert Consultation and Specialty Services - Mental HealthBiography
Dr. Moore is a psychiatrist at VA Connecticut and directs the VISN 1 Clinical Resource Hub (CRH). The VISN 1 CRH provides mental health, primary care, and specialty care services across New England to underserved VA facilities. His research is in the implementation of complex clinical services treatments via telemedicine and how virtual training programs can support the adoption of evidence-based practices. He is PI for the VA Office of Rural Health (ORH) National Mental Health and Suicide Prevention ECHO and mPI for the VA ORH National TeleNephrology Hub and Spoke Network.
Appointments
Education & Training
- Chief Resident in Quality and Safety
- Yale School of Medicine and VA Connecticut (2017)
- Resident
- Yale School of Medicine (2016)
- PhD
- Perelman School of Medicine at the University of Pennsylvania, Biochemistry and Molecular Biophysics (2012)
- MD
- Perelman School of Medicine at the University of Pennsylvania (2012)
- MSc
- University of Virginia (2002)
- BA
- University of Virginia, Echols - Interdisciplinary (2000)
Board Certifications
Psychiatry
- Certification Organization
- American Board of Psychiatry & Neurology
- Original Certification Date
- 2016
Research
Research at a Glance
Yale Co-Authors
Frequent collaborators of David Moore's published research.
Publications Timeline
A big-picture view of David Moore's research output by year.
Susan T Crowley, MD, MBA, FASN
12Publications
Publications
2023
Implementing a Successful Tele-Nephrology Program for Rural Veterans
Bonegio R, Tuozzo K, Rifkin I, Kroll-Desrosiers A, Crowley S, Mattocks K, Moore D. Implementing a Successful Tele-Nephrology Program for Rural Veterans. Journal Of The American Society Of Nephrology 2023, 34: 729-729. DOI: 10.1681/asn.20233411s1729c.Peer-Reviewed Original Research
2015
The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in Platelets.
Wu Y, Span LM, Nygren P, Zhu H, Moore DT, Cheng H, Roder H, DeGrado WF, Bennett JS. The Tyrosine Kinase c-Src Specifically Binds to the Active Integrin αIIbβ3 to Initiate Outside-in Signaling in Platelets. J Biol Chem 2015, 290: 15825-15834. PMID: 25947380, DOI: 10.1074/jbc.M115.648428.Peer-Reviewed Original Research
2012
Affinity of talin-1 for the β3-integrin cytosolic domain is modulated by its phospholipid bilayer environment.
Moore DT, Nygren P, Jo H, Boesze-Battaglia K, Bennett JS, DeGrado WF. Affinity of talin-1 for the β3-integrin cytosolic domain is modulated by its phospholipid bilayer environment. Proc Natl Acad Sci U S A 2012, 109: 793-8. PMID: 22210111, DOI: 10.1073/pnas.1117220108.Peer-Reviewed Original Research
2011
Computational design of a β-peptide that targets transmembrane helices.
Shandler SJ, Korendovych IV, Moore DT, Smith-Dupont KB, Streu CN, Litvinov RI, Billings PC, Gai F, Bennett JS, DeGrado WF. Computational design of a β-peptide that targets transmembrane helices. J Am Chem Soc 2011, 133: 12378-81. PMID: 21780757, DOI: 10.1021/ja204215f.Peer-Reviewed Original ResearchTransmembrane communication: general principles and lessons from the structure and function of the M2 proton channel, K⁺ channels, and integrin receptors.
Grigoryan G, Moore DT, DeGrado WF. Transmembrane communication: general principles and lessons from the structure and function of the M2 proton channel, K⁺ channels, and integrin receptors. Annu Rev Biochem 2011, 80: 211-37. PMID: 21548783, DOI: 10.1146/annurev-biochem-091008-152423.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2010
NMR analysis of the alphaIIb beta3 cytoplasmic interaction suggests a mechanism for integrin regulation.
Metcalf DG, Moore DT, Wu Y, Kielec JM, Molnar K, Valentine KG, Wand AJ, Bennett JS, DeGrado WF. NMR analysis of the alphaIIb beta3 cytoplasmic interaction suggests a mechanism for integrin regulation. Proc Natl Acad Sci U S A 2010, 107: 22481-6. PMID: 21156831, DOI: 10.1073/pnas.1015545107.Peer-Reviewed Original ResearchRegulation of platelet beta 3 integrins.
Bennett JS, Moore DT. Regulation of platelet beta 3 integrins. Haematologica 2010, 95: 1049-51. PMID: 20595101, DOI: 10.3324/haematol.2010.024893.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2008
Protein-protein interactions in the membrane: sequence, structural, and biological motifs.
Moore DT, Berger BW, DeGrado WF. Protein-protein interactions in the membrane: sequence, structural, and biological motifs. Structure 2008, 16: 991-1001. PMID: 18611372, DOI: 10.1016/j.str.2008.05.007.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2006
Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb.
Yin H, Litvinov RI, Vilaire G, Zhu H, Li W, Caputo GA, Moore DT, Lear JD, Weisel JW, Degrado WF, Bennett JS. Activation of platelet alphaIIbbeta3 by an exogenous peptide corresponding to the transmembrane domain of alphaIIb. J Biol Chem 2006, 281: 36732-41. PMID: 17032655, DOI: 10.1074/jbc.M605877200.Peer-Reviewed Original ResearchArylamide derivatives as allosteric inhibitors of the integrin alpha2beta1/type I collagen interaction.
Yin H, Gerlach LO, Miller MW, Moore DT, Liu D, Vilaire G, Bennett JS, DeGrado WF. Arylamide derivatives as allosteric inhibitors of the integrin alpha2beta1/type I collagen interaction. Bioorg Med Chem Lett 2006, 16: 3380-2. PMID: 16678410, DOI: 10.1016/j.bmcl.2006.04.037.Peer-Reviewed Original Research
Academic Achievements and Community Involvement
activity Moderator
Meeting Planning and ParticipationYale Medical Student Safety and Communication WorkshopDetails2016 - Presentactivity Moderator
Meeting Planning and ParticipationYale Medical Student Safety and Communication WorkshopDetails2016 - Presentactivity Faculty Member
Media PresenceYale School of Medicine NewsDetails2019 - 2019activity Instructor
Meeting Planning and ParticipationYale Psychiatry Clerkship mental Status Exam AssessmentDetails2015 - 2018activity Expert
Public ServiceConnecticut General AssemblyDetails2017 - 2017
Links & Media
News
- December 01, 2023
Garcia Vasallo Launches Training Program to Enhance Substance Use Disorder Care in Underserved Communities
- March 06, 2022
Through the VA Connecticut Clinical Resource Hub, Yale Clinicians Provide Specialty Care to Communities Where It Is Scarce or Unavailable
- August 23, 2019
VA Connecticut to be Nationally Designated Clinical Resource Hub
- November 08, 2018Source: Yale Medicine
Health and Healing for Our Veterans
Get In Touch
Contacts
Email